Sutro Biopharma Inc.

NASDAQ: STRO · Real-Time Price · USD
0.73
-0.09 (-10.44%)
At close: May 14, 2025, 2:22 PM

Sutro Biopharma Revenue Breakdown

Period Ending Dec 31, 2024
Research and Development Services Revenue 174K
Research and Development Services Revenue Growth n/a

Operating Expense Breakdown

Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selling, General, and Administrative Revenue 9.03M 14.33M 12.37M 10.96M 15.07M 15.27M 15M 15.51M 14.72M 14.64M 15.14M 15.04M 15.76M 16.59M 12.54M 11.11M 10.38M 9.08M 8.64M 8.71M 8.7M 8.12M 8.07M 7.71M 7.57M 5.35M 4.04M 4.41M 4.07M 4.89M 3.71M 3.71M
Selling, General, and Administrative Revenue Growth -36.99% +15.84% +12.87% -27.29% -1.28% +1.80% -3.31% +5.39% +0.52% -3.30% +0.69% -4.59% -4.98% +32.24% +12.95% +6.97% +14.36% +5.04% -0.80% +0.21% +7.15% +0.60% +4.56% +1.86% +41.54% +32.42% -8.45% +8.51% -16.89% +32.10% 0.00% n/a
Research and Development Revenue 71.04M 62.11M 62.02M 56.88M 53.77M 45.67M 41.59M 39.4M 43.13M 31.71M 32.33M 29.99M 29.93M 26.6M 25.31M 22.56M 22.74M 19.36M 17.24M 17.62M 17.39M 16.9M 16.14M 15.18M 14.79M 12.64M 13.75M 13.08M 15.14M 13.67M 12.91M 12.91M
Research and Development Revenue Growth +14.38% +0.14% +9.04% +5.79% +17.73% +9.80% +5.57% -8.66% +36.01% -1.91% +7.81% +0.21% +12.50% +5.11% +12.18% -0.77% +17.44% +12.28% -2.13% +1.31% +2.93% +4.67% +6.34% +2.66% +16.97% -8.06% +5.11% -13.59% +10.76% +5.84% 0.00% n/a